Norris Cotton Cancer Center
About Us News & Events Careers How to Help
Patient Care For Patients & Visitors For Cancer Professionals Cancer Research Clinical Trials Regional Locations
Search

Cornelius J. Cornell Jr. MD

Contact Information:
Phone: (603) 650-5747
Fax: (603) 650-6786
Email: not given

Institution Affiliations:
Professor of Medicine (Hematology/Oncology) & of Pediatrics
Department of: MEDICINE
Section: Hematology/Oncology
Specialty: Hematology/Oncology
Joined Staff: 1975

Cancer Center Membership:
Blood and Marrow Transplant Program
Lymphoma / Leukemia Clinical Oncology Group
Hemophilia Program

Clinical Interests:
Myeloproliferative Disorders
Hemophilia
Board Certified:
Hematology/Oncology
Hematology
Hemophilia
Degree(s): MD
New York Medical College, New York, NY 1966

Internship(s):
Henry Ford Hospital, Detroit, MI, (Internal Medicine) 1966-67

Residency:
Dartmouth-Hitchcock Medical Center, Hanover, NH, (Internal Medicine) 1971-73

Fellowship(s):
Dartmouth-Hitchcock Medical Center, Hanover, NH, (Hematology/Oncology) 1973-75

Biography:
Dr. Cornell received his BS from Wheaton College in 1962 and his MD from New York Medical College in 1966. Following services in the U.S. Navy, he completed his residency in internal medicine and a fellowship in Hematology and Oncology at the Mary Hitchcock Memorial Hospital. He has been a member of the Dartmouth Medical School faculty since 1975 and he is Director of the Hemophilia Center.

Research Interests:
Dr. Cornell's research interests include the use of non-plasma derived agents for the treatment of hemophilia and the study of blood product safety in collaboration with the World Health Organization/CDC.

Selected Publications:
Ornstein DL, Lord KE, Yanofsky NN, Cornell CJ, Zacharski LR. Successful donation and transplantation of multiple organs after fatal poisoning with brodifacoum, a long-acting anticoagulant rodenticide: Case report. Transplantation, 67(3):475-478, February 15, 1999.
Cornell C, Gill J, Bergman G. Safety and efficacy of Stimate (desmopressin acetate, 1.5 mg/ml) nasal spray in patients with mild hemophilia A. Trombosis and Hemostasis, Supp 1997.
Kritz A, Read J, Ely P, Cornell C, Mills L, Brighton S, Stearns D, Roach M, Lowrey C. Use of Peripheral Blood Progenitors (PBP) to allow high dose Ara-C (HDAC) consolidation cycles in elderly patients with AML. Blood, 88:284b, 1996. Abstract.
Malone M, McKernan L, Cornell CJ. Comparison of efficacy of intravenous desmopressin acetate (DDAVP) and high concentrate DDAVP in nasal spray (Stimate) for hemostatic disorders. Hemophilia, 2:12, 1996. Abstract.
  

NCI Logo